Clinical Trials Sponsored by EyeGene Inc.

Total 35501 results

EyeGene Inc.

Recruiting

Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult

COVID-19

Australia
EyeGene Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

COVID-19 Vaccine

Australia
enGene, Inc.

Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Superficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

United States
EyeGene Inc.
Novotech (Australia) Pty Limited

Completed

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers

Prevention of Herpes Zoster (HZ)

Australia
Eyegate Pharmaceuticals, Inc.

Completed

Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy ("PRK")

Refractive Surgery | Ophthalmology | Photorefractive Keratectomy ("PRK") | Laser Assisted Surgery

United States
Eyegate Pharmaceuticals, Inc.

Completed

Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery

Pain, Postoperative | Cataract | Anterior Chamber Inflammation

United States
Eyegate Pharmaceuticals, Inc.

Completed

OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)

Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal

United States
Eyegate Pharmaceuticals, Inc.

Terminated

Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema

Macular Edema

United States
EdiGene (GuangZhou) Inc.

Active, not recruiting

A Safety and Efficacy Study Evaluating ET-01 in Subjects With Transfusion Dependent β-Thalassaemia (ET-01)

Transfusion Dependent Beta-Thalassaemia

China
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye

Dry Eye

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis

Uveitis, Anterior

United States, India
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.

Corneal Epithelial Wound

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL

Cataract

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis (EGP-437-006)

Anterior Uveitis

United States
Eyegate Pharmaceuticals, Inc.

Completed

PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy

Vitrectomy

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis

Anterior Uveitis

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye

Dry Eye Syndrome

United States
Eyegate Pharmaceuticals, Inc.

Completed

Safety and Tolerability Study of Transscleral Iontophoresis by the EyeGate® II Drug Delivery Device System

Healthy

India
Laboratoire Boreaderme Inc.
Ecogene 21

Unknown

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Recurrent Herpes Labialis
EdiGene (GuangZhou) Inc.
PLA 923 Hospital

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia.

Transfusion Dependent Beta-Thalassaemia

China
EyeSense GmbH

Completed

Clinical and Home Use Feasibility Study of a Percutaneous Optical Glucose Fiber Sensor

Diabetes (DM)

Germany
Daniel Gaudet
Ultragenyx Pharmaceutical Inc

Active, not recruiting

Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia

Homozygous Familial Hypercholesterolemia

Canada
EyeSense GmbH

Recruiting

Feasibility Study of a Transdermal Continuous Glucose Monitoring (CGM) System in Diabetic Patients

Diabetes

Germany
EyeSense GmbH

Terminated

Investigation of a Sub-Conjunctival Insert

Diabetes Care

Germany
Chinese PLA General Hospital
Peking University; EdiGene Inc.

Recruiting

TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

Non Hodgkin's Lymphoma

China
Sangamo Therapeutics
Ceregene

Completed

Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease

United States
Sangamo Therapeutics
Ceregene

Completed

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Sangamo Therapeutics
Ceregene

Completed

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

Parkinson's Disease

United States
Center Eugene Marquis

Not yet recruiting

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer (CRANIUM)

HER2-positive Breast Cancer
Center Eugene Marquis

Recruiting

Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2) (Lip-Re2)

Hepatocellular Carcinoma Non-resectable

France
Center Eugene Marquis

Suspended

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer (SIROCHO)

Resectable Intrahepatic Cholangiocarcinoma

France
Center Eugene Marquis

Completed

Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTIX)

Oropharynx Cancer

France
Center Eugene Marquis

Completed

Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors (GLIROPA)

Brain Neoplasms | Adult Brain Tumor

France
Center Eugene Marquis

Terminated

Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer (EnergiePancrea)

Metastatic Pancreatic Cancer

France
Center Eugene Marquis

Completed

Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients (AVA-CELL)

Glioma | Glioblastoma

France
Center Eugene Marquis

Recruiting

Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy (TEMPOS)

Prostate Cancer

France
Center Eugene Marquis

Recruiting

Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops. (ESTAUVAL)

Breast Cancer | Surgery

France
Center Eugene Marquis

Completed

Evaluation of Music on the Level of Anxiety Felt During External Radiotherapy Sessions (MUSIC-RT)

Radiotherapy Side Effect

France
Center Eugene Marquis

Active, not recruiting

Comparison of Humeral or Thoracic Implantation of an Central Veinous Access by an Implantable Venous Access Device in Patients With Solid Tumors Requiring Chemotherapy (PACPAC-EPOC)

Solid Tumor, Adult | Chemotherapy Treatment | Advanced or Metastasis Stage

France
Center Eugene Marquis

Completed

Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma (MispheC)

Cholangiocarcinoma

France
Center Eugene Marquis

Terminated

Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer (VesiCaP)

Overactive Bladder

France
iRegene Therapeutics Co., Ltd.

Recruiting

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Parkinson Disease

China
Center Eugene Marquis

Withdrawn

Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma. (INFLAGLI)

Glioma
Center Eugene Marquis

Completed

Adaptative Radiotherapy for Locally Advanced Cervical Cancer (ARCOL)

Uterine Cervical Cancer

France
Center Eugene Marquis

Completed

Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTOME) (ARTOME)

Oropharynx Cancer

France
Center Eugene Marquis

Completed

Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer (TEmPoRAL)

Locally Advanced Malignant Neoplasm | Malignant Neoplasm of Head and Neck

France
Center Eugene Marquis

Completed

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis (CONVERCE)

Malignant Melanoma

France
Center Eugene Marquis

Completed

Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry

Adenoma, Liver Cell

France
Center Eugene Marquis

Terminated

Essential Oils on Anxiety of Patients Suffering From Cancer (RHECAP)

Neoplasm Metastasis

France
Center Eugene Marquis

Completed

Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium (ICY)

Hepatocellular Carcinoma

France

3

Subscribe